KU receives $5.8 million NIH Phase 3 COBRE funding for Chemical Biology of Infectious Disease center
September 25, 2026
September 25, 2026
LAWRENCE, Kansas, Sept. 25 -- The University of Kansas posted the following news:
* * *
KU receives $5.8 million NIH Phase 3 COBRE funding for Chemical Biology of Infectious Disease center
*
LAWRENCE -As antibiotic resistance makes everyday infections tougher to treat and emerging pathogens drive challenging infectious-disease outbreaks, researchers in Kansas from multiple disciplines and institutions are teaming up to target pathogens and over . . .
* * *
KU receives $5.8 million NIH Phase 3 COBRE funding for Chemical Biology of Infectious Disease center
*
LAWRENCE -As antibiotic resistance makes everyday infections tougher to treat and emerging pathogens drive challenging infectious-disease outbreaks, researchers in Kansas from multiple disciplines and institutions are teaming up to target pathogens and over . . .